Recently, researchers from Columbia University's Aaron Diamond AIDS Research Center published a paper in the journal Vaccines, with an impact factor of 7.8, on the results of a research study on the development of a SARS-CoV-2 vaccine based on the NanoGeneratorTM Flex System, which demonstrated a major breakthrough in the application of the LNP technology to the development of a COVID vaccine. LNP technology has made a major breakthrough in the application of LNP technology, which can be successfully applied to the development of COVID vaccines.